76 related articles for article (PubMed ID: 19924028)
1. Severe gastrointestinal bleeding and thrombocytopenia in a child with an anti-GATA1 autoantibody.
de Waele L; Freson K; Louwette S; Thys C; Wittevrongel C; de Vos R; Debeer A; van Geet C
Pediatr Res; 2010 Mar; 67(3):314-9. PubMed ID: 19924028
[TBL] [Abstract][Full Text] [Related]
2. Neuraminidase-induced thrombocytopenia in mice: effects on thrombopoiesis.
Stenberg PE; Levin J; Baker G; Mok Y; Corash L
J Cell Physiol; 1991 Apr; 147(1):7-16. PubMed ID: 2037624
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
Nugent D; McMillan R; Nichol JL; Slichter SJ
Br J Haematol; 2009 Sep; 146(6):585-96. PubMed ID: 19466980
[TBL] [Abstract][Full Text] [Related]
4. Efficient assay for evaluating human thrombopoiesis using NOD/SCID mice transplanted with cord blood CD34+ cells.
Suzuki K; Hiramatsu H; Fukushima-Shintani M; Heike T; Nakahata T
Eur J Haematol; 2007 Feb; 78(2):123-30. PubMed ID: 17087740
[TBL] [Abstract][Full Text] [Related]
5. The relationship between megakaryocyte ploidy and platelet volume in normal and thrombocytopenic C3H mice.
Corash L; Levin J
Exp Hematol; 1990 Oct; 18(9):985-9. PubMed ID: 2397753
[TBL] [Abstract][Full Text] [Related]
6. Critical role of CD4(+)CD25(+) regulatory T cells in preventing murine autoantibody-mediated thrombocytopenia.
Nishimoto T; Satoh T; Takeuchi T; Ikeda Y; Kuwana M
Exp Hematol; 2012 Apr; 40(4):279-89. PubMed ID: 22240606
[TBL] [Abstract][Full Text] [Related]
7. Severe Thrombocytopenia in the NICU.
Baer VL; Lambert DK; Henry E; Christensen RD
Pediatrics; 2009 Dec; 124(6):e1095-100. PubMed ID: 19917581
[TBL] [Abstract][Full Text] [Related]
8. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis.
Nagata Y; Shozaki Y; Nagahisa H; Nagasawa T; Abe T; Todokoro K
Thromb Haemost; 1997 May; 77(5):808-14. PubMed ID: 9184382
[TBL] [Abstract][Full Text] [Related]
9. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia.
Radder CM; Brand A; Kanhai HH
Am J Obstet Gynecol; 2001 Sep; 185(3):683-8. PubMed ID: 11568798
[TBL] [Abstract][Full Text] [Related]
10. Acute bleeding and thrombocytopenia after bone marrow transplantation.
Nevo S; Enger C; Hartley E; Borinsky ME; Swan V; Fuller AK; Braine HG; Kickler TS; George JN; Vogelsang GB
Bone Marrow Transplant; 2001 Jan; 27(1):65-72. PubMed ID: 11244439
[TBL] [Abstract][Full Text] [Related]
11. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
[TBL] [Abstract][Full Text] [Related]
12. Effects of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia induced by a new myelosuppressive chemotherapy regimen in mice.
Akahori H; Shibuya K; Ozai M; Ida M; Kabaya K; Kato T; Miyazaki H
Stem Cells; 1996 Nov; 14(6):678-89. PubMed ID: 8948025
[TBL] [Abstract][Full Text] [Related]
13. Sustained thrombocytopenia in mice: serial studies of megakaryocytes and platelets.
Stenberg PE; Levin J; Corash L
Exp Hematol; 1990 Feb; 18(2):124-32. PubMed ID: 2303104
[TBL] [Abstract][Full Text] [Related]
14. Thrombocytopenia in chronic hepatitis C.
Olariu M; Olariu C; Olteanu D
J Gastrointestin Liver Dis; 2010 Dec; 19(4):381-5. PubMed ID: 21188328
[TBL] [Abstract][Full Text] [Related]
15. Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant.
Shimizu R; Kobayashi E; Engel JD; Yamamoto M
Genes Cells; 2009 Sep; 14(9):1119-31. PubMed ID: 19682090
[TBL] [Abstract][Full Text] [Related]
16. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
Chow FP; Zsebo K; Hamburger AW
Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
[TBL] [Abstract][Full Text] [Related]
17. Treatment of the Kasabach-Merritt syndrome with pegylated recombinant human megakaryocyte growth and development factor in mice: elevated platelet counts, prolonged survival, and tumor growth inhibition.
Verheul HM; Panigrahy D; Flynn E; Pinedo HM; D'Amato RJ
Pediatr Res; 1999 Nov; 46(5):562-5. PubMed ID: 10541319
[TBL] [Abstract][Full Text] [Related]
18. GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis.
Saultier P; Cabantous S; Puceat M; Peiretti F; Bigot T; Saut N; Bordet JC; Canault M; van Agthoven J; Loosveld M; Payet-Bornet D; Potier D; Falaise C; Bernot D; Morange PE; Alessi MC; Poggi M
J Thromb Haemost; 2021 Sep; 19(9):2287-2301. PubMed ID: 34060193
[TBL] [Abstract][Full Text] [Related]
19. Antenatal treatment of alloimmune thrombocytopenia.
Lynch L; Bussel JB; McFarland JG; Chitkara U; Berkowitz RL
Obstet Gynecol; 1992 Jul; 80(1):67-71. PubMed ID: 1603500
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietic effect of VPAC1 inhibition during megakaryopoiesis.
Peeters K; Loyen S; Van Kerckhoven S; Stoffels K; Hoylaerts MF; Van Geet C; Freson K
Br J Haematol; 2010 Oct; 151(1):54-61. PubMed ID: 20735399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
